Dr. Ross Matthew Kennamer-Chapman, MD

  • Peachtree City, GA
  • Ophthalmologist
NPI1245765601PAC ID3678972742
Medicare services, 2024
21,550
Medicare patients, 2024
895
Part D claims, 2024
708
Publications
1
MIPS score, 2024
95
Practice address
403 Westpark Ct, Peachtree City, GA 30269
Practice phone
Call (404) 255-9096
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Georgia Retina

Peachtree City, Georgia

See all 4 affiliations

Find Dr. Kennamer-Chapman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ross Matthew Kennamer-Chapman is an ophthalmologist in Peachtree City, Georgia

Dr. Kennamer-Chapman practices at Georgia Retina in Peachtree City, Georgia.

Dr. Kennamer-Chapman's NPI, 1245765601, was assigned on April 24, 2017. Dr. Kennamer-Chapman graduated from University of Texas Medical School at Houston in 2017. Dr. Kennamer-Chapman holds Georgia license 95752.

NPI and contact details
Medicare PAC ID
3678972742
NPI enumeration date
April 24, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(404) 255-9096
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
35
Medical school graduation
2017

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ross Matthew Kennamer-Chapman practices at Georgia Retina in Peachtree City, Georgia

Dr. Kennamer-Chapman's primary practice is Georgia Retina, at 403 Westpark Ct, Peachtree City, GA 30269 in Fayette County. The practice phone is (404) 255-9096.

  • Georgia Retina
    403 Westpark Ct, Peachtree City, GA 30269 · Fayette CountyPhone(404) 255-9096

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Ross Matthew Kennamer-Chapman is affiliated with 3 sites of care and 1 medical group

Dr. Kennamer-Chapman's primary practice is Georgia Retina in Peachtree City, Georgia. Dr. Kennamer-Chapman is also affiliated with Northside Hospital Atlanta. Dmand AI also links Dr. Kennamer-Chapman to 1 more group practice or clinic and 1 medical group, each named with a free account.

See all 4 affiliations for Dr. Kennamer-Chapman

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Ross Matthew Kennamer-Chapman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kennamer-Chapman practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Georgia RetinaAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kennamer-Chapman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ross Matthew Kennamer-Chapman is one of 484 ophthalmologists in Georgia

Ophthalmology is Dr. Kennamer-Chapman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Kennamer-Chapman's licenses on file in 2 states: Georgia and Missouri.

Specialties and state licenses

  • Ophthalmology, GeorgiaPrimaryLicense 95752 · taxonomy 207W00000X
  • Missouri licenseLicense 2021010436

Ophthalmologists near Dr. Kennamer-Chapman

Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.

484ophthalmologists in Georgia
2ophthalmologists in Peachtree City

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ross Matthew Kennamer-Chapman billed Medicare for 21,550 services in 2024

CMS data shows 21,550 Medicare services from Dr. Kennamer-Chapman across 17 procedure codes in 2024, for 895 Medicare patients. Medicare paid $1,472,104 for them.

Medicare services, 202421,550
Medicare patients895
Paid by Medicare$1.5M
Procedure codes17

Dr. Kennamer-Chapman's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 4,5952024: 17,567282%
Tests and treatments
2023: 7902024: 2,915269%
Surgery
2023: 2132024: 845297%
Office and hospital visits
2023: 712024: 187163%
Imaging
2023: 262024: 3638%

Where Dr. Kennamer-Chapman's Medicare services took place, 2024

  • In an office21,535100%
  • In a facility150%

Dr. Kennamer-Chapman compared with the Georgia median for ophthalmologists, 2024

  • Dr. Kennamer-Chapman
  • Georgia median
Medicare services
21,550vs 1,58613.6 times
Medicare patients
895vs 57256% above
Part D claims
617vs 89131% below

Medians across 477 ophthalmologists in Georgia with Dmand AI profiles that report each measure.

Dr. Kennamer-Chapman's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kennamer-Chapman

Need commercial claims for Dr. Kennamer-Chapman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kennamer-Chapman and other ophthalmologists in Georgia.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ross Matthew Kennamer-Chapman treated 895 Medicare patients in 2024, average age 76

CMS counts 895 Medicare patients who saw Dr. Kennamer-Chapman in 2024. The largest group is 65 to 74, with 389 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kennamer-Chapman's median patient age at 68, with 58% women.

Medicare patients, 2024895
Average age76
Average risk score1.39
Also on Medicaid7%

Dr. Kennamer-Chapman's Medicare patients by age, 2024

Dr. Kennamer-Chapman's Medicare patients by sex, 2024

  • Women49155%
  • Men40445%

Chronic conditions among Dr. Kennamer-Chapman's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis42%
  4. Diabetes41%
  5. Chronic kidney disease38%
  6. Ischemic heart disease32%
  7. Atrial fibrillation20%
  8. Anxiety19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kennamer-Chapman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women58%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ross Matthew Kennamer-Chapman wrote 708 Medicare Part D claims in 2024

In 2024, Dr. Kennamer-Chapman wrote 708 Medicare Part D claims for 219 patients. 55% of them were for generic drugs. CMS names the drug for 617 of them, across 11 drugs with 11 or more claims each, at $21,077 in total drug cost. In 2023, CMS named 210 claims across 9 drugs.

Part D claims, 2024708
Drugs named by CMS11
Total drug cost$21,077
Part D patients219

Dr. Kennamer-Chapman's Part D claims by kind of drug, 2024

  • Generic386 claims55%
  • Brand-name322 claims45%

Dr. Kennamer-Chapman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2102024: 617194%

Drugs named by CMS: 11 in 2024, 9 in 2023.

See all prescribing by Dr. Kennamer-Chapman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Ross Matthew Kennamer-Chapman scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kennamer-Chapman for performance year 2024, reported through an alternative payment model (APM). Dr. Kennamer-Chapman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Kennamer-Chapman's MIPS scores, performance year 2024

  • 95of 100Final score
  • 80.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find ophthalmologists like Dr. Kennamer-Chapman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ross Matthew Kennamer-Chapman has 1 publication on record

Dmand AI links 1 paper to Dr. Kennamer-Chapman in 2024. Dr. Kennamer-Chapman's most frequent co-authors are Lee M. Jampol, MD and Rithwick Rajagopal, MD.

Papers1

Dr. Kennamer-Chapman's most frequent co-authors

Recent publications by Dr. Kennamer-Chapman

See all 1 publications and co-authors

See who Dr. Kennamer-Chapman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kennamer-Chapman works with, so you can find a warm path to the right ophthalmologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Ross Matthew Kennamer-Chapman received $3,290 in industry payments from 2023 to 2025

CMS Open Payments shows 83 general payments to Dr. Kennamer-Chapman from 12 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. ANI Pharmaceuticals, Inc. paid the most, $485.

General payments to Dr. Kennamer-Chapman by program year, 2023 to 2025

Companies that paid Dr. Kennamer-Chapman the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kennamer-Chapman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Ross Matthew Kennamer-Chapman graduated from University of Texas Medical School at Houston

Dr. Kennamer-Chapman graduated from University of Texas Medical School at Houston in 2017.

  1. Medical schoolUniversity of Texas Medical School at Houston

Source: Dmand AI Professional Profile Data

Sources for Dr. Ross Matthew Kennamer-Chapman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ross Matthew Kennamer-Chapman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ross Matthew Kennamer-Chapman's NPI number?

Dr. Ross Matthew Kennamer-Chapman's NPI number is 1245765601. It was assigned on April 24, 2017, and it is active in the NPI Registry.

What kind of doctor is Dr. Ross Matthew Kennamer-Chapman?

Dr. Ross Matthew Kennamer-Chapman is an ophthalmologist in Peachtree City, Georgia. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).

Where does Dr. Ross Matthew Kennamer-Chapman practice?

Dr. Kennamer-Chapman practices at 403 Westpark Ct, Peachtree City, GA 30269. Dr. Kennamer-Chapman's primary practice is Georgia Retina in Peachtree City, Georgia. Dmand AI also links Dr. Kennamer-Chapman to 1 group practice or clinic and 1 medical group.

What is Dr. Ross Matthew Kennamer-Chapman's office phone number?

The practice phone on file for Dr. Kennamer-Chapman is (404) 255-9096.

What is Dr. Ross Matthew Kennamer-Chapman's medical license number?

Dr. Kennamer-Chapman holds Georgia license 95752, one of the licenses on file in 2 states.

Which states has Dr. Ross Matthew Kennamer-Chapman been licensed in?

Dmand AI has state licenses on file for Dr. Kennamer-Chapman in Georgia and Missouri.

Which hospitals is Dr. Ross Matthew Kennamer-Chapman affiliated with?

Dr. Kennamer-Chapman is affiliated with Northside Hospital Atlanta.

Does Dr. Ross Matthew Kennamer-Chapman accept Medicare?

Yes. CMS data shows Dr. Kennamer-Chapman billed Medicare for 21,550 services in 2024, and Dr. Kennamer-Chapman accepts Medicare assignment.

What is Dr. Ross Matthew Kennamer-Chapman's MIPS score?

Dr. Kennamer-Chapman's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Ross Matthew Kennamer-Chapman see?

CMS counts 895 Medicare patients who saw Dr. Kennamer-Chapman in 2024, with an average age of 76.

Show 7 more questionsShow fewer questions

What services does Dr. Ross Matthew Kennamer-Chapman bill to Medicare?

In 2024, Dr. Kennamer-Chapman's most billed Medicare services were injected or infused drug (J2777), eye exam or test (92134) and injected or infused drug (J0177).

Where did Dr. Ross Matthew Kennamer-Chapman go to medical school?

Dr. Kennamer-Chapman graduated from University of Texas Medical School at Houston in 2017.

What drugs does Dr. Ross Matthew Kennamer-Chapman prescribe most?

In 2024 Medicare Part D data, Dr. Kennamer-Chapman's most prescribed drugs by claims were Prednisolone Acetate, Ketorolac Tromethamine and Atropine Sulfate.

Has Dr. Ross Matthew Kennamer-Chapman received payments from drug or device companies?

CMS Open Payments shows $3,290 in general payments to Dr. Kennamer-Chapman from 12 companies from 2023 to 2025. The largest total came from ANI Pharmaceuticals, Inc.

How long has Dr. Ross Matthew Kennamer-Chapman been practicing?

Dr. Kennamer-Chapman graduated from medical school in 2017, 9 years ago.

Does Dr. Ross Matthew Kennamer-Chapman do research?

Dmand AI links 1 publication to Dr. Kennamer-Chapman.

Who does Dr. Ross Matthew Kennamer-Chapman publish with?

Dr. Kennamer-Chapman's most frequent co-authors are Lee M. Jampol, MD (1 shared paper) and Rithwick Rajagopal, MD (1 shared paper).

Selling to ophthalmology practices?

See ophthalmologists in Georgia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)